Life360, Inc. (ASX:360) has disclosed that director Charles J. Prober exercised 7,930 stock options and sold 7,930 shares of common stock on 13 November 2026, pursuant to a Rule 10b5-1 trading plan adopted on 14 March 2025, according to a Form 4 filed with the United States Securities and Exchange Commission.
Key Points
- Director Charles J. Prober exercised 7,930 stock options at an exercise price of $11.18 per share on 13 November 2026.
- Prober disposed of 7,930 shares of common stock at $43.70 per share on the same date on NASDAQ.
- Following the transactions, Prober directly held 109,930 shares of Life360 common stock, including 3,361 restricted stock units.
- The transactions were executed under a Rule 10b5-1 trading plan adopted on 14 March 2025, when Prober was not aware of any material non-public information about the company.
- The stock option exercised was fully vested and had an expiration date of 12 April 2028; following exercise, Prober held zero remaining options under that grant.
Stock Option Exercise and Share Sale Details
According to the Form 4 filing, Charles J. Prober, a director of Life360, exercised a fully vested stock option covering 7,930 shares of common stock at an exercise price of $11.18 per share on 13 November 2026. On the same date, Prober disposed of 7,930 shares at a price of $43.70 per share on the NASDAQ. The company disclosed that a portion of the shares sold was used to cover the exercise price and associated tax withholding obligations. Following both transactions, Prober directly held 109,930 shares of Life360 common stock.
Rule 10b5-1 Trading Plan
The transactions were carried out under a Rule 10b5-1 trading plan that Prober adopted on 14 March 2025. As disclosed in the filing, a Rule 10b5-1 trading plan is a written, pre-established arrangement that provides for the automatic sale of company stock pursuant to predetermined criteria. Life360 stated that the reporting person adopted the plan at a time when they were not aware of any material non-public information about the company. The Form 4 was signed by Jay Sood as attorney-in-fact on 17 November 2026.
Beneficial Ownership Following Transactions
Following the reported transactions, Prober's direct beneficial ownership stood at 109,930 shares of Life360 common stock. The filing noted that this figure includes 3,361 restricted stock units previously granted, each representing a contingent right to receive one share of the issuer's common stock upon vesting. The stock option that was exercised, which carried an exercise price of $11.18 and an expiration date of 12 April 2028, was fully consumed in the transaction, leaving Prober with zero remaining options under that grant. The announcement was authorised by Russell Burke, Chief Financial Officer of Life360.



Please wait processing your request...